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Abstract
Binge drinking is the most lethal of drinking patterns, responsible for 77% of
all U.S. alcohol misuse costs. Adolescents have increased sensitivity to ethanol’s
rewarding properties and decreased sensitivity to ethanol’s aversive effects likely
allowing for their increased binge drinking, as compared to adults. Ethanol
consumption during adolescent neurodevelopment can lead to immediate and
lasting neurobiological-consequences. We have previously shown that adolescent
intermittent binge ethanol exposure decreases myelin-related gene expression in
DBA/2J mice. Here, we hypothesize intermittent binge ethanol exposure in
adolescent DBA/2J mice will decrease myelin protein expression in the prefrontal
cortex (PFC) immediately following binge ethanol and this may persist into
adulthood. Adolescent DBA/2J mice (PND 29-42) were intermittently dosed with
4g/kg ethanol or water through oral gavage. Markers of puberty onset and sexual
maturation were tracked in males and females to assess if ethanol affects sexual
development. To assess immediate and persistent effects of binge ethanol
exposure, PFC was harvested in adolescence (PND 43) and adulthood (PND 66),
cryosectioned and immunostained for myelin basic protein (MBP). Western
blotting was conducted to provide a complementary semi-quantitative technique to
further assess the effects of binge ethanol exposure on MBP and PLP protein
expression. We found that binge ethanol did not significantly alter myelin protein
expression, specifically for MBP and PLP. However, we noted that ethanol males
displayed a slight trend towards decreased protein expression in adolescence. In
addition, we found that adult control females had significantly more PLP protein
expression as compared to control males in adulthood (PND 84). Thus, we added
to our previous mRNA findings with a potential trend towards decreased MBP and
PLP expression in ethanol males at the protein level and found sex differences.
Further work to verify these trends is needed. Together, these findings help
elucidate the potential effects of ethanol on white matter integrity in the PFC and
bolster our earlier mRNA findings at the protein level, which may provide the
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framework for future studies to uncover a mechanism by which ethanol acts to
disrupt white matter.
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Chapter 1: INTRODUCTION
Throughout history, alcohol has served as the multifaceted drug of choice
for numerous Americans (Olson and Gerstein 1985). The consumption of alcohol
leads to general central nervous system (CNS) depression, in part, because of
increased levels of the major inhibitory neurotransmitter GABA and decreased
levels of the major excitatory neurotransmitter glutamate (Costardi et al 2015).
This altered neurochemistry may lead to decreased social inhibition and reduced
anxiety (Banerjee 2014; Valdez et al 2002). These social incentives coupled with
alcohol’s relative availability, increase its abuse potential (Simons et al 2009). The
excessive use of alcohol leads to the development of physiological dependence on
the drug, making treatment and long-term abstinence difficult for affected
individuals (Kendall et al 2011). Additionally, the psychosocial ramifications that
occur with the progression of the disease compound the effects of this disorder;
there are concerns for maintenance of relationships, job status and overall mental
health when alcoholism is unmanaged (Kendall et al 2011). Thus, alcohol abuse is
complex and multifaceted because of the interplay of the biological, social and
psychological consequences.
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In 2013, the Diagnostic and Statistical Manual of Mental Disorders
(DSM-V) combined alcohol abuse and alcohol dependence into a single diagnosis
of Alcohol Use Disorder or AUD with eleven specified symptoms (Mewton et al
2010). From the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a
2018 National Survey on Drug Use and Health (NSDUH) revealed approximately
5.8% of adults (ages eighteen years or older) had AUD with 7.6% of this group
being male and 5.3% female (NIAAA, 2018). For the adolescent age group (ages
12-17), NSDUH revealed 1.6 % of adolescents had an AUD with 1.4% and 1.9%
being males and females respectively (NIAAA 2018). The public health concerns
related to alcohol misuse are vast. The NIAAA noted that alcohol was the third
leading cause of preventable death in America with approximately 88,000
alcohol-related deaths occurring annually (NIAAA 2018).
Regarding the financial strains of alcohol misuse, the United States spent
249 billion dollars in 2010 alone; approximately three-quarters of this total cost
was related to binge drinking (NIAAA 2018). Binge drinking is a drinking pattern
that raises an individual’s blood alcohol concentration (BAC) to a level greater
than or equal to 0.08 grams percent; this BAC level is typically achieved after five
drinks in males and four drinks in females within a two hour timeframe (CDC
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2019). The CDC states that 90% of American individuals consume alcohol in the
form of binge drinking. This statistic is of significance because binge drinking is
the most lethal drinking pattern (CDC, 2019). Binge drinking is most common in
younger individuals including the ages 18-34 years old (majority of adolescents),
with this pattern of drinking being two times more likely in men than women
(CDC, 2019).
Ethanol Mechanism of Action
Ethanol is a psychotropic depressant that can result in major neurobiological
alterations when consumed in excess (Costardi et al 2015). These molecular
consequences stem from ethanol’s structure and subsequent mechanism of action.
Ethanol is a small polar compound with structural features that confers
amphiphilicity. This dual hydrophobic and hydrophilic quality allows ethanol to
enter the hydrophobic blood-brain-barrier where it precipitates a generally
depressive effect on the CNS. Ethanol’s amphiphilicity makes for a promiscuous
drug of abuse. Ethanol binds to CNS receptor systems including but not limited to
gamma-aminobutyric acid (GABA) receptors, NMDA receptors, acetylcholine
receptors, and serotonin receptors and alters these neuronal systems as a result
(Costardi et al 2015). Ethanol functions, in part, by enhancing the actions of the
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major CNS inhibitory neurotransmitter GABA by
acting as a positive allosteric

modulator (PAM) and allowing the endogenous chemical to exert a greater
inhibitory or depressive effect on the CNS (Olsen and Liang 2017). Ethanol also
inhibits the major CNS excitatory neurotransmitter, glutamate, by functioning as a
negative allosteric modulator (NAM) and suppressing glutamatergic activity
(Mihov 2016). Thus, this coupled action leads to an overall depressed CNS
susceptible to neurobiological harm if chronic alcohol abuse continues.
Alcohol and Adolescent Neurodevelopment
Adolescence is defined as a transitional period with severe social pressures
and notable neurodevelopmental changes (Spear 2013). Studies have revealed both
regressive and progressive development occurring within the adolescent brain
through extensive synaptic pruning and increased myelination (Giedd et al, 1996;
Sowell et al 1999; Spear 2013). Myelin is the lipid rich substance that insulates the
axonal processes of the neurons thereby augmenting the conduction of electrical
transmission within the nerve cell during the process of saltatory conduction; the
bundles of myelinated axons constitute the white matter in the CNS (Filley 2005;
Morell and Quarles 1999). Thus, the presence of myelin leads to increased
conduction velocity that enhances communication and processing within the CNS.
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These ongoing developmental changes in the adolescent brain may affect the
behavior of this demographic because of the neural alterations taking place (Spear
2000).
In particular, the prefrontal cortex (PFC) is one of the last regions to develop
due to the caudal to rostral growth pattern of the human brain (Arain et al 2013).
This delayed maturation of PFC accounts for the increased risk taking seen in
adolescents; the PFC is an associative region implicated in impulse control and
higher order executive functioning (Wilson et al 2010). Thus, adolescents are more
likely to engage in risk taking behavior (Arain et al 2013). Adolescents’ excessive
consumption of alcohol demonstrates their proclivity for risky behavior (Spear
2000). In addition, adolescents’ propensity to consume alcohol in excess is likely
attributed to their increased sensitivity to the rewarding aspects of alcohol and
decreased sensitivity to the aversive properties (Spear 2005).
Regarding adolescent binge drinking, loosely defining this age range from
12 years old to approximately 25 years old, there was an estimated 4.3 million
people within this group that engaged in binge drinking (NIAAA, 2018). The
concern for this illegal underage alcohol use not only highlights the need for more
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stringent underage drinking laws, but may lead to potential neurobiological
consequences.
These neurobiological consequences may lead to lasting, deleterious effects
including possible memory deficits, emotional abnormalities due to alterations in
the a mygdala, attention impairments, d
 ecreased hypothalamic-pituitary axis
activity and decreased white matter in the frontal cortex (Oscar-Berman and
Marinković 2007; Spear 2014). The decrease in myelination will yield downstream
effects on brain maturation (Spear and Swartzwelder 2014). Numerous human and
rodent studies have sought to further elucidate the mechanisms by which ethanol
affects adolescent neurodevelopment.
Epidemiological findings revealed earlier onset of alcohol consumption is a
strong predictor of a later AUD diagnosis (Grant et al 1998; Spear 2000). This
finding gives credence to the proposed theory that adolescence is a critical period
(Spear 2000). The presumed lack of temperance among the adolescent population
coupled with the significant neural alterations occurring during this time warrant
the need for further investigation in adolescent neuropathology. However, seminal
studies assessing the neurobiological consequences of ethanol mainly incorporated
adults in the experimental models (Charness, 1993; Pfefferbaum et al., 1997).
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Adolescent studies revealed the potential consequences of early onset
drinking patterns. For example, an adolescent MRI human study revealed that
subjects with adolescent onset AUD had smaller PFC regions and decreased white
matter volume in this brain region, compared to controls (De Bellis et al 2005).
The investigators also found thalamus, brainstem, cerebellar volumes did not differ
between control subjects and those with AUD, suggesting that the PFC region may
be particularly vulnerable following ethanol exposure in adolescence (De Bellis et
al 2005). Additional studies have determined other notable findings with respect to
adolescent neurobiology and alcohol.
McQueeny et al found that adolescent binge drinkers (with no prior AUD
diagnosis) displayed a comparatively lower fractional anisotropy (FA) ratio in the
numerous white matter areas including the corpus callosum, limbic, brainstem and
cortical projection fibers compared to controls. FA is defined as a scalar value that
ranges between zero and one, to describe the degree of anisotropy in a given
diffusion process, thus it serves as a robust metric for quantifiably assessing the
integrity of white matter (McQueeny et al 2009). This finding provided preliminary
evidence that because the adolescent brain is not fully formed, drugs of abuse such
as alcohol may result in undesirable consequences, including but not limited to
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decreased white matter in various brain regions.

Indeed, the introduction of

alcohol into the adolescent CNS is associated with deleterious effects that may
culminate into potential neuropsychological (NP) impairments. Tapert et al
investigated twenty-two NP variables through interviews and two hour NP battery
of tests. They determined five factors including attention, memory, visuospatial,
language, and intrusion resistance accounted for a majority of the variance in NP
scores between groups. In particular, attention performance was significantly
related to substance use patterns throughout the 4 year period, with recent
adolescent abusers having the worst performance in the attention NP test and
non-abusers having the best performance. This NP impairment suggests that
ethanol may lead to certain cognitive deficits.
Adolescent drinking studies in learning and memory have found evidence of
differential effects between binge drinking and control groups (Schweinsburg et al
2010; Sneider et al 2012). In a human study employing a virtual human analogue
of the Morris Water Maze task, binge drinking and controls (light drinking)
“emerging adults” (ages ranging between 21-23) demonstrated a poorer
performance on verbal memory tasks compared to controls with no notable
differences in spatial memory between the two groups (Sneider et al 2012). Binge
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drinkers also displayed worse learning as compared to the controls. A functional
magnetic resonance imaging (fMRI) study assessing learning and memory through
verbal encoding tasks, found that control subjects (nondrinkers) showed significant
hippocampal activation during novel encoding, while binge drinkers showed more
responses in the frontal region during verbal encoding, suggesting use of working
memory but not long-term memory (Schweinsburg et al 2010). Thus, these
findings support the associated potential learning and memory impairments
involved with binge drinking. Indeed, the neurobiological compromise of the white
matter manifests into altered cognitive functioning for the persons that use this
drug of abuse.
However, the adolescent human model is not without ethical restriction and
complex variability investigating the mechanisms of unclear neurocognitive
sequelae (Kottegoda et al 1988; Mandal et al 2011; Tsay 2015). Rodent model
organisms, while with their own ethical guidelines (Frussa-Filho 2015; Meerburg
et al 2008; Nattrass et al 2018; Nuffield Council on Bioethics 2005), allow for
controlled experimental study of the various consequences of alcohol (Coleman et
al 2011; Richardson et al 2014; Wolstenholme et al 2017). Preclinical rodent
studies have improved the understanding of the underlying molecular mechanisms
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that are causing the neurocognitive deficits. For example, adolescent binge ethanol
treatment in C57BL/6 (C57) mice (5g/kg/day i.g., postnatal development (PND)
days 28-37) altered gene expression of neurotransmitters in the adult (PND 60-88)
brain (Coleman et al 2011). In particular, mRNA gene expression of cholinergic
neurotransmitters were reduced after ethanol; the cholinergic neurotransmitters are
implicated in cognitive processing in the forebrain. The loss of cholinergic
neurotransmitters and forebrain structures after ethanol treatment could uncover
the molecular mechanism of adult reversal learning deficits after adolescent
alcohol exposure.
Additionally, binge-like ethanol administration in adolescent rats increases
neuroimmune activation in the PFC that precipitates neuroinflammation and
demyelination processes in the PFC that will have long-term consequences on
adult cognitive processing (Pascual et al 2014). These experimental findings
support the prevailing theory that the adolescent brain is particularly sensitive to
the neurotoxic effects of ethanol. Crews et al provided seminal findings that further
support the vulnerability of the adolescent brain and its susceptibility to
ethanol-induced neurotoxicity (Crews et al 2000). Binge ethanol exposure in both
adolescent and adult rats led to damage in the olfactory bulb mainly in the
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glomeruli, however there is differential sensitivity in ages; with juvenile rats
exhibiting increased damage to the frontal cortical region, and piriform cortices as
compared to adult rats. These brain regions are implicated in memory and
integrated cognitive processes, thus their damage in adolescence could result in
long-term consequences in adulthood (Crews et al 2019).
Persistent Neural Effects of Ethanol
The underlying mechanisms of persistent neurobiological alterations in the
presence of ethanol are still under investigation (Crews et al 2019; Ehlers et al
2010). However, the potential for white matter recovery following alcohol
abstinence further complicates the role alcohol plays in neurotoxicity and
demyelination (Miller and Fyffe-Maricich et al 2010; Pfefferbaum et al 2014; Zahr
et al 2015). There is a growing preponderance of evidence that alcohol persistently
impacts the CNS. Ethanol causes the release of dopamine through the
mesocorticolimbic reward pathway (Brodie 1999). Dopamine (DA) is a
neurochemical that plays a significant role in the PFC, enabling higher order
cognitive functioning, including but not limited to attention and behavioral
flexibility (Puig 2014). Repeated binge ethanol exposure during adolescence
negatively alters dopaminergic neurotransmitters in the medial PFC (mPFC) by
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hyper-methylation of the promoter region of Catechol-O-methyltransferase
(COMT), a DA degradative enzyme (Trantham-Davidson et al 2017). This
hypermethylation of COMT leads to decreased regulation of DA that may disrupt
PFC development and cognitive control. These negative alterations are possible
contributors to the limited behavior control and cognitive deficits observed in
adults that consumed alcohol during adolescence. The N-methyl-D-aspartate
(NMDA) receptor system implicated in synaptic plasticity and dendritic
morphology contains the GluN2B subunit, which is an ethanol sensitive
component. In a preclinical rodent study, adolescent intermittent ethanol (AIE)
exposure (PND 30-45) altered GluN2B associated proteins in the hippocampus of
adult (PND 70)

Sprague-Dawley rats (Swartzwelder et al 2016). Therefore,

ethanol-induced changes to these proteins are possible molecular contributors to
the persistent changes observed in adult hippocampus following AIE.
Sex differences and Alcohol
While the prevalence of alcohol use has been consistently observed to be
greater in men (Grant et al 1997; Warner et al 1995; Wilsnack et al 2009) the
gender gap is closing (Keyes 2007). In general, females were more likely to
engage in heavy drinking activity and under report this behavior (Keyes 2007;
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Wagoner et al 2013). These differences in alcohol use may be attributed to the
morphological differences in the brains of males and females.
Sexual dimorphism of white matter is still an area requiring further
investigation, with the degree of influence from sexual hormones as compared to
sex chromosomes on differential white matter microstructure remaining somewhat
unclear. A diffusion tensor imaging (DTI) study with men, women, and women
with genetic complete androgen insensitivity syndrome (CAIS) found that men
displayed higher FA ratio in thalamus, basal ganglia and brainstem regions
compared to both women groups while women and women with CAIS had
relatively similar FA ratios in the aforementioned regions; genetic CAIS women
(46,XY karyotype) appear phenotypically female and typically possess elevated
luteinizing hormone (LH), estradiol and testosterone levels with a mutant
nonfunctional androgen receptor (van Hemmen et al 2017). The CAIS women and
46, XX karyotype women possessed no significant differences in estradiol levels,
while both groups of women had higher estradiol levels than the men. These
findings suggest that the differences in white matter microstructures between sexes
are possibly attributed to sexual hormones more so than genetics.
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The differences in white matter microstructure are further illustrated with the
introduction of ethanol. In a human magnetic resonance spectroscopy study, brain
metabolism in both control males and females along with alcoholic males and
females was assessed with the N-acetylaspartate, a marker for neuronal activity
(Schweinsburg et al 2003). Alcoholic males and females displayed decreased
N-acetylaspartate in the frontal lobe, but female subjects (alcoholic and control)
had significantly lower concentrations of N-acetylaspartate, suggesting that the
differences in white matter may affect brain metabolism. Preclinical animal studies
have shown that males have greater density of myelin compared to females
(Cerghet et al 2009; Roughton et al 2013; Yang et al 2008). Thus, it is logical that
females have been observed to be more vulnerable to the negative effects of
alcohol use (Johnston et al 2009; Schulte et al 2009).
However, there is limited evidence of ethanol’s effects in both males and
females’ white matter integrity. Preclinical studies have sought to further elucidate
the role of sex as a biological variable. Richardson et al have shown that
self-administration of alcohol leads to decreased myelin density in the mPFC in
male rats (Richardson et al 2014). In a follow up study including male and female
rats, ethanol-drinking patterns were similar between the sexes. However, ethanol
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self-administration did not significantly change myelin density in the anterior
cingulate division of mPFC in females but this effect was seen in males
(Richardson et al 2019). These sex differences in myelin alteration may be
correlated with the sex differences in pubertal onset and sexual maturation.
Adolescence encompasses the period of sexual maturation i.e. puberty. Females
generally mature faster than males and there are noted sex differences because of
the hormonal increases during puberty (Spear 2000). Therefore, it is possible that
sexual maturation and puberty onset may serve as a marker when assessing effects
of ethanol treatment (Dees and Skelley 1990; Dees et al 2000).
Our laboratory has shown that adolescent binge ethanol exposure decreases
myelin related gene expression in the adolescent PFC of DBA/2J (DBA) mice with
males having a more robust decrease than females in four myelin-related genes
including myelin basic protein (Mbp) and proteolipid (Plp) (Wolstenholme et al
2017). These findings prompt the question of the existence of alterations at the
protein level between males and females that may lead to these differential effects
in myelin density.
Myelin related proteins and Alcohol
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The myelin sheath found in the CNS that surrounds the axonal processes of
neurons is a product of the glial cells, namely, oligodendrocytes (del-Rio Hortega
1921). Glial cells are structural support cells that greatly enhance the
neurotransmission within the CNS. The unique myelin-related proteins in the CNS
have been well characterized (Davison 1989). In particular, MBP and PLP are two
major structural myelin related proteins present in mature oligodendrocytes (Boggs
2006; Nadon et al 1998).
These myelin-related proteins have been shown to decrease in the frontal
cortex and hippocampus, after continued drug abuse (Lee et al 2010; Smith et al
2014). MBP is highly abundant in the CNS myelin and belongs to a
conformationally adaptable protein family with 4 classic isoforms (Smith 2012).
The exact functions of the MBP isoforms have not been fully determined.
However, studies reveal that two of the

isoforms (18.5 kDa and 14.0 kDa)

predominate in compact myelin (Akiyama et al 2002; Boggs and Harauz 2013;
Devine-Beach et al 1989) suggesting that these isoforms possess a structural role
along with PLP to maintain the myelin in the CNS, while the other isoforms (21.5
kDa and 17.0 kDa) are re-expressed in remyelination lesions in multiple sclerosis
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models (Akiyama et al 2002; Capello et al 1997) suggesting a possible role in
remyelination.
PLP is ubiquitous in the CNS. It plays a significant role in the maturation of
oligodendrocytes and acts to form and maintain the lipid-rich, multilamellar
structure of myelin (Nadon et al 1998; Yamaguchi et al 1996). Mutations in the
Mbp and Plp genes that encode these myelin related proteins are associated with
demyelination (Duncan and Radcliff 2016; Yamaguchi et al 1996). However, more
studies are needed to assess alterations of myelin at the protein level. The
abundance of these two major structural proteins and their ability to cause potential
myelin alterations in the CNS make them appropriate targets for experimental
study.
We have previously determined that binge ethanol exposure decreases
myelin related gene expression in DBA/2J (DBA) mice (Wolstenholme et al 2017).
Additionally, we conducted a smaller scale pilot study assessing the protein
expression of MBP and PLP. PLP showed a significant decrease and MBP showed
a downward trend (Wolstenholme and Rahmipour; unpublished work ca 2015).
Thus, the prior studies provided the framework for the proposed project to assess
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myelin related alterations in the PFC through the assessment of MBP and PLP
protein expression.
We hypothesize that adolescent binge ethanol exposure will decrease MBP
and PLP protein expression in the PFC of adolescent DBA mice. In aim one, we
assessed the immediate effects of binge ethanol exposure on adolescent DBA mice
(PND 43) through immunohistochemistry and Western Blots. We hypothesized
ethanol treated animals would show decreased myelin-related protein expression.
In aim two, we assessed the persistent effects of adolescent binge ethanol exposure
on adult DBA mice after three weeks of abstinence. We hypothesized that
alterations in myelin-related protein expression would persist into adulthood with
ethanol treated animals showing greater decreases in myelin-related protein
expression. In aim three, we specifically analyzed sex differences in both
adolescents and adults following binge ethanol exposure, and we tracked pubertal
onset/pubertal progression in order to assess if ethanol affects sexual maturation.
We hypothesized that ethanol treated males would display a decrease in
myelin-related proteins compared to their female counterparts. Together, the goal
of these studies will be to further elucidate the structural effects of binge ethanol
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exposure in adolescents, and in doing so, provide further scientific evidence of the
immediate and lasting effects of ethanol consumption.
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Chapter 2: METHODS
Animals
Two cohorts of male and female DBA/2J mice were purchased from Jackson
Laboratories East (Bar Harbor, ME) and housed in the animal vivarium on the
eighth floor of VCU Kontos Medical Sciences Building. The mice arrived at 20-21
days postnatal development (PND 20-21) and acclimated to the vivarium for one
week. The animals were kept on a 12 hour-12 hour light-dark cycle with food and
water available ad libitum throughout the course of the experiment.
The experimenter administered 0.2 milliliters of a 0.1% saccharin solution
(0.045 grams saccharin, 45 mL sterile filtered tap water) to each mouse from PND
26/27-28 to habituate the mice to the oral gavage procedure. The mice were then
divided into ethanol treatment and control groups (n = 7-8 per group, 3-5 mice per
cage) and counterbalanced by body weight.
From PND 29-42, mice followed an intermittent dosing schedule (Figure 1)
with ethanol treated animals receiving a 4g/kg dose of a 25% w/v ethanol solution
in sterile filtered tap water and vehicle animals receiving sterile filtered tap water
for two consecutive days followed by two days of abstinence (dosing days included
29-30, 33-34, 37-38, 41-42) (Wolstenholme et al, 2017). Ethanol solutions were
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remade for each two-day dosing period. For each dosing day, animals were
weighed, re-tail marked and administered the required volume of either ethanol or
water; body weights were recorded daily on dosing days throughout the
experiment. All conducted experiments were in accordance with the Institutional
Animal Care and Use Committee of Virginia Commonwealth University.

Estrus and Testes Assessment
For the second cohort of animals (25 females and 24 males) puberty onset
and progressive sexual maturation were tracked throughout the second adolescent
binge ethanol study into adulthood (PND 50/51). These assessments were
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completed to assess if ethanol affects sexual development, to assess the association
between sexual maturation and myelin-related protein expression, and to assess
potential sex differences in PFC development. Human studies have found
conflicting evidence regarding the introduction of ethanol and sexual maturation
(Damgaard et al, 2007; Kjersgaard et al 2018). Similarly, rodent studies have not
come to a consensus regarding ethanol consumption and sexual maturation (Dare
et al 2002; Priddy et al 2017).
However, the fact remains that adolescence encompasses a definitive period
of sexual maturation i.e. puberty (Spear 2000). Thus, markers for onset of the
estrus cycle in females and testes descent in males were used in order to further
analyze sex differences following binge ethanol exposure.
Females were placed on the top of a metal cage and allowed a brief period of
habituation. The experimenter then held the animal with her non-dominant hand,
such that the hind paws were at the edge of the cage and the tail was gently pulled
up orthogonal to the experimenter’s non-dominant hand (Ekambaram et al 2017).
The animal’s vaginal area was assessed for pinkness, swelling and presence of a
vaginal opening (VO). The Jackson Laboratory estrus cycle chart (Figure 2) was
used as a reference to assist with visual assessment (Byers et al 2012; Jax.org).
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The source of lighting during estrus assessment remained constant and the
experimenter ensured that the lighting permitted precise observations. We opted to
use visual estrus assessment over vaginal cytology because the procedure is less
stressful (Champlin et al 1973) and our laboratory frequently conducts behavioral
assays to assess anxiety-like phenotypes (e.g. anxiety-like behavior in the
light-dark box, Wolstenholme, et al 2017). Thus, we did not seek to further stress
the mice with the vaginal lavage procedure involved with vaginal cytology.
Various experimenters in the field have espoused visual estrus cycle staging
as a gentler and reliable form of assessment (Byers et al 2012; Champlin et al
1973). DBA/2J mice have been reported as a more difficult strain for estrus staging
(Champlin et al 1973) however, the main assessment involved evaluating the
animals for the VO event which was relatively clear across all animals (Byers et al
2012; Ekambaram et al 2017). Throughout the collection of estrus data, a
confidence assessment was taken that described the experimenters’ overall
confidence in staging the animals. The confidence level ranged from “low,”
“medium,” to “high.” The experimenters’ confidence increased with subsequent
assessments.
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Male mice were habituated to the metal cage in the same fashion as females.
The experimenter then lifted the animal’s tail and gently pressed just above the
hind paw to check for the presence of testicular swelling. Males were then raised to
the eye level of the experimenter and peripheral assessment of testicular “drop”
was completed. Finally, the male mouse was checked for the presence of a
darkened area surrounding the genitalia.
Similarly to the estrus assessments, a confidence assessment was taken to
describe the experimenters’ confidence level when tracking testes descent. The
scoring rubric included a numeric score of 3 which corresponds to a “Yes”
indicating full testes descent i.e. bilateral testicular swelling, a medium to large
testicular drop from side view, and a medium to large darkened area around the
genital area. The animal received a numeric score of 2 corresponding to “yes
part/maybe” indicating the animal was in partial testes descent with bilateral
testicular swelling, a small to medium testicular drop from side view and a medium
sized darkened area surrounding the genitalia. A numeric score of 1 represents
“no” indicating the animal had no distinguishable testicular swelling, no testicular
drop from side view and a small sized darkened area surrounding the external
genitalia. All animals were handled with care throughout these assessments.
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Tissue harvest
In experiment 1, for immunostaining, PFC was harvested either twenty-four
hours following the last ethanol binge dose (PND 43, immediate time point) or
three weeks following the last ethanol binge dose (PND 66, persistent time point).
Animals were organized to ensure that ethanol treated animals and control animals
were counterbalanced during the terminal transcardial perfusions. Animals were
sedated with isoflurane and transcardially perfused with 4% paraformaldehyde (40
g paraformaldehyde, 9 g NaCl, 800 mL MilliQ water, pH 7.4) for ten minutes; the
flow rate of the perfusion pump was 0.827 ml/min.
Following the perfusion, animals were decapitated, the skull was removed
and the brain was extracted. Brain tissue was then placed in 40 mL vials of
paraformaldehyde stored at 4 o C for a twenty-four hour post fixation period. Tissue
was then transferred into 40 mL of 30% sucrose cryoprotectant solution (780 g
sucrose; 0.01 M phosphate buffered saline (PBS) solution, for detailed recipe for
PBS solution see Appendix) for forty-eight hours to ensure the integrity of the
morphology remained intact (i.e. prevent ice crystals from forming inside the brain
tissue and disrupting the cellular components of the brain tissue) (Hossain and
Osuamkpe 2007). Tissue was placed in isopentane (beaker of isopentane was
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placed in a bucket of dry ice) and frozen. Frozen tissue was stored at -80 oC until
cryosectioning (see Appendix for detailed cryosectioning methods).
In experiment 2, for Western blotting, mice were sacrificed through terminal
cervical dislocation and a rapid decapitation procedure. Brain tissue was harvested
at postnatal development days 43 and 84. Brains were placed into a chilled beaker
of 0.9% saline solution (9 g NaCl, 700 mL deionized water, 300 mL MilliQ water)
for thirty seconds. Brains were then oriented with the ventral side facing up, and
placed on a chilled dissecting block. The olfactory bulb was removed, then a
wedge-shaped cut was made; this wedge-shaped tissue dissection included the
medial prefrontal cortex (mPFC, 1.40 mm distance from bregma to 0.50 mm),
anterior cingulate cortex (ACC), sensory cortex, and motor cortex. Tissue
dissections were stored at -20oC until tissue homogenization.
Myelin Basic Protein (MBP) immunostaining
64 animals were selected from both the immediate harvest time point (PND
43) and the persistent harvest time point (PND 66, n= 8 per sex/treatment, 4 groups
per time point). A series of 5-8 25 um coronal sections (with region of interest
(ROI) prefrontal-cortex present) per animal were placed into a 12-well plate
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(Corning, Corning, NY, catalogue # 3513) with three 12-well plates used for both
the persistent and immediate time points, 6 plates total).
Sections were washed in 0.01 M PBS twice, for five minutes each wash.
Sections were then blocked in PBS solution with 0.5% Triton (PBS-T) (5% normal
goat serum, Jackson ImmunoResearch, West Grove, PA, catalogue # 005-000-121;
0.5% Triton X 100; 0.01 M PBS solution) for thirty minutes at room temperature
with gentle agitation. Sections were incubated in MBP anti-rat primary antibody
solution with 400 ul per well (1:1000, Abcam, Cambridge, UK, catalogue # 7349;
3.2 mL PBS-T; 3% normal goat serum) overnight at 4 oC with gentle agitation.
Sections were subsequently washed three times in PBS for ten minutes each with
gentle agitation. Sections were then incubated in the Invitrogen Alexa Fluor 594
goat anti-rat secondary antibody solution (1:1000, Thermo Fisher, Waltham, MA,
catalogue # A11007; 0.5% Triton X 100; 3.2 mL 0.01 M PBS) for two hours with
gentle agitation and protected from light. Sections were then washed in PBS three
times for ten minutes each wash and stored in PBS at 4 o C until mounting. Each
animals’ sections were placed in a separate indent free container containing PBS
and transferred to a Fisherbrand Superfrost microscope slide (Fisher Scientific,
Waltham, MA, catalogue # 12-55-0-143).
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Sections were organized into columns with the most rostral section first and
the most caudal section last. Excess PBS was pipetted from the microscope slide
and slides were left to dry for a short period. Vectashield Vibrance Antifade
mounting medium with DAPI counterstain for CNS nuclei (VECTOR
Laboratories, Burlingame, CA, catalogue # H-1800) was used to mount sections
further, with 50 ul added to each slide. Slides were coverslipped with Corning
Cover Glass rectangle coverslips (Corning, Corning, NY, catalogue # 2980-245)
and sealed with clear nail polish. Sections for one ethanol male animal were
destroyed during the tissue mounting portion of the experiment, leading to an N =
63 for the immunohistochemistry study. See Appendix for detailed methods on
MBP immunostaining.
Myelin Proteolipid (PLP) immunostaining
The initial intent of this project was to assess immediate and persistent
effects of binge ethanol exposure on myelin-related proteins MBP and PLP protein
expression in the PFC (PLP anti-mouse, Millipore, Burlington, MA, catalogue #
MAB388). Due to the fact that using an anti-mouse antibody on mouse brain tissue
could lead to non-specific binding to the endogenous proteins expressed in the
murine brain section (see Appendix for PLP immunostaining on C57BL/6J
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untreated tissue), we used the Basic Mouse-on-Mouse (M.O.M) immunodetection
kit (VECTOR Laboratories, Burlingame, CA, catalogue # BMK-2202) to block the
Invitrogen Alexa Fluor 594 goat anti-mouse secondary antibody (Thermo Fisher,
Waltham,

MA,

catalogue

# A32742) from detecting the endogenous

immunoglobulins through a Avidin-Biotin Complex (ABC) system (Xing et al
2019). We conducted a -/+ PLP MOM kit experiment with negative controls and
varying concentrations (PLP 1:250, PLP 1:500). See Appendix for detailed
methods for -/+ PLP MOM kit experiment and images.

Image acquisition and quantification
Images were acquired using the Olympus DP74 microscope (Olympus Life
Science, Tokyo, Japan) with cellSense Standard software (Olympus Life Science,
Tokyo, Japan). Each section had a representative image taken of both hemispheres
in the Cy3 light at the 10X objective (scale bar was present on each 10X image).
Images for quantification were taken at the 20X objective with a constant exposure
of 24.9 milliseconds and the Super Fluorescence (SFL) setting for all images.
Sections ranged from 1.40 mm distance from bregma to 0.50 mm from bregma; no
section imaged at the 20X objective included the corpus callosum (see Appendix
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for detailed supplemental methods on image acquisition and quantification
including image exclusion criteria). Following the quantification, three mice from
the persistent time point including one control male and two ethanol males were
removed because of excess damage to the region of interest leading to N = 60 for
the immunohistochemistry study.

Western Blots
Fifty-three dissected PFC tissue samples (control and ethanol treated
animals, immediate and persistent time points, n= 6-8 per group, 4 groups per time
point) were sonicated with a chilled volume of 150 ul RIPA buffer (2.5 mL of 1M
Tris, pH 8.0; 1.5 mL of 5M NaCl; 0.5 mL of Triton x 100; 0.5 mL of 0.5M EDTA;
0.25 g sodium deoxycholate, 50 mL MilliQ water) with HALT protease inhibitor
(1:100 concentration in RIPA buffer, Thermo Fisher, Waltham, MA, catalogue #
78440) in order to lyse the cells and extract protein from the samples (Peach et al
2015). Sample lysates were stored at -20 oC until used in order to prevent
premature denaturation of protein samples. The BCA protein assay was performed
using Pierce BCA Assay kit (Thermo Fisher, Waltham, Massachusetts, catalogue #
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23227; see Appendix for more detailed BCA assay methods) in order to calculate
protein concentration (Walker 1994).
After sample preparation, the samples along with the Chameleon ™ Kit
Prestained ladder/molecular weight marker to estimate the unknown protein
quantities (LICOR, Lincoln, NE, catalogue # P/N: 928-90000) were separated
through sodium-dodecyl sulfate polyacrylamide gel electrophoresis with NuPage
4-12% Bis-Tris Protein gels (Thermo Fisher, Waltham, MA, catalogue #
NP0329BOX) in 0.01 M MES SDS running buffer at 150 V for approximately 45
minutes (see Appendix for detailed methods on gel electrophoresis and sample
preparation) using the Thermo Fisher mini gel tank apparatus and Bio-Rad
PowerPac Basic power supply (Bio-Rad Laboratories, Hercules, CA, catalogue #
1645050).
PVDF membranes were soaked in 100% methanol for 5 minutes, followed
by four washes in MilliQ water. Membranes were then soaked in transfer buffer
(50 mL of NuPage transfer buffer, Thermo Fisher, Waltham, MA, catalogue #
NP00061; 200 mL of 100% methanol, Sigma-Aldrich, St. Louis, MO, catalogue #
322415; 749 mL of MilliQ water; 1 mL of antioxidant, Thermo Fisher, Waltham,
MA, catalogue # NP0005). Western blot transfer was performed with the Bio-Rad
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PowerPac supply set to 27 V for a one hour transfer period at 4 oC. Following
transfer, membranes were air-dried for at least one hour and rehydrated in 100%
methanol for one minute. Membranes were then washed in MilliQ-water between
three and four times followed by a two minute wash in 0.01 M tris-buffered saline
(TBS) wash (see Appendix for detailed TBS recipe). Membranes were
subsequently blocked with Intercept TBS Blocking buffer (LICOR, Lincoln, NE,
catalogue # P/N: 927- 60001) for one hour with gentle agitation (plate shaker was
used to provide gentle agitation) at room temperature.
Membranes were then probed with primary antibodies MBP anti-rat (1:1000;
Abcam, Cambridge; United Kingdom, catalogue # 7439; 7.5 mL Intercept
Blocking buffer; 0.2% Tween-20; 0.02% w/v sodium azide), Beta-actin anti-mouse
(1:10,000; Abcam, United Kingdom; catalogue # 8266; 7.5 mL Intercept Blocking
buffer; 0.2% Tween-20; 0.02% w/v sodium azide) and kept on a gentle plate rocker
for overnight incubation at 4 oC. Following overnight incubation, membranes were
briefly rinsed in TBS with 0.1% Tween-20 (TBS-T) followed by a five minute
TBS-T wash repeated four times (all washes were completed at room temperature
with gentle agitation provided by the plate shaker).
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Membranes were then probed with IRDye 800 CW Goat anti-Rat Secondary
Antibody (1:30,000, LICOR, Lincoln, NE, catalogue # P/N: 926-32219; 0.2%
Tween-20; 0.02% SDS solution; 7.5 mL Intercept Blocking buffer) and IR-Dye
680 RD Goat anti-Mouse Secondary Antibody (1:30,000; LICOR, Lincoln, NE;
catalogue # P/N: 926-68070; 0.2% Tween-20; 0.02% SDS solution). Membranes
were light protected and incubated in secondary antibody solution for one hour at
room temperature with gentle agitation. After the secondary antibody incubation
period, membranes were briefly rinsed in TBS-T followed by a five minute TBS-T
wash with gentle agitation; the TBS-T wash was repeated for a total of four times.
Membranes were then rinsed in the TBS buffer and stored at 4 oC until imaging.
Membranes were imaged using the LICOR detection system and Odyssey software
and quantified using ImageJ software (NIH, Bethesda Maryland). For detailed
methods on membrane imaging, see Appendix.
Following the imaging, membranes were stripped of antibodies using
NewBlot IR Stripping buffer for NIR Western Blots (LICOR; Lincoln, NE;
catalogue # P/N: 928-40028), blocked in Intercept Blocking buffer for fifteen
minutes and reprobed with anti-PLP antibody (1:5,000; 0.2% Tween-20; 0.02%
w/v sodium azide) followed by IRDye 800 CW Goat anti-Mouse Secondary
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Antibody (1:30,000, LICOR, Lincoln, NE, catalogue # P/N: 926-32210; 0.2%
Tween-20; 0.02% SDS solution). LICOR immunodetection system and ImageJ
software were used for analysis and quantification of PLP relative abundance (see
Appendix for detailed methods on membrane stripping and reprobing for
PLP-antibody).
Following the imaging steps, one ethanol female (immediate time point) was
not included in protein quantification because the signal of the target protein was
absent (despite the presence of the loading control protein in the corresponding
lane). In the persistent time point, one ethanol male, one ethanol female, and one
control female were not included in protein quantification for similar reasons.
Thus, N = 49 (n = 5-8 per group, 4 groups per time point).
Statistical Analysis
Based on our findings that Mbp and Plp mRNA levels were robustly
decreased in adolescent ethanol treated animals compared to controls (PND 43)
and that these alterations in gene expression did not persist into adulthood (PND
66), we formed the a priori hypotheses that ethanol will decrease myelin protein
expression and this decrease in myelin protein expression will persist into
adulthood. We conducted separate two-way ANOVA statistical analyses for each
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time point in order to specifically assess the potential for recovery. In order to
ensure there was no significant variability in the loading control protein expression,
two-way ANOVAs with sex and treatment as factors were completed for actin area
values for both immediate (PND 43) and persistent (PND 84) samples; no post-hoc
tests were required.
To assess potential sex differences and potential treatment effects of ethanol
in the MBP and PLP protein expression measured from the fluorescent-based
Western blots, two-way ANOVA with sex and treatment as factors were performed
with alpha level set to 0.05. No post hoc tests were required. To specifically assess
sex differences, we conducted two-way ANOVA with sex and time point as factors
for control animals only; Student-Newman-Keuls post hoc analyses were
completed as needed. The alpha level was set to 0.05 for all statistical tests. All
statistical testing and analysis was done using SigmaPlot 14 (Systat software,
Chicago, IL), GraphPad Prism8 (GraphPad Software, San Diego, CA) and JMP
Pro 14 (SAS Institute, Cary, NC).
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Chapter 3: RESULTS
Optimization and specificity of MBP antibody
We first titrated our MBP antibody (1:1000, 1:1500) on C57BL/6J
(untreated tissue) and included a negative control (Alexa Fluor 594 1:1000, no
primary antibody) in order to determine the optimal concentration and ensure that
we were accurately localizing our target of interest. We determined that MBP at
1:1000 concentration was optimal compared to the 1:1500 concentration, as MBP
1:1000 displayed a stronger MBP signal (without excess saturation) than the more
dilute concentration which displayed a lower fluorescent intensity. We used the
corpus callosum (DBA/2J strain; treated tissue) as an anatomical landmark to
ensure we were visualizing specific myelin staining (Figure 3).
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MBP immunoreactivity in adolescent PFC tissue (PND 43)
We used an MBP antibody as a protein marker for myelin to assess changes
in MBP expression through semi-quantitative immunohistochemistry. Our
experimental design included four groups (i.e. control males, control females,
ethanol males, and ethanol females). All mice in this study were intermittently
dosed with a 4g/kg of ethanol or water from PND 29-42. We sought to assess
potential alterations immediately following adolescent binge ethanol exposure.
Thus, we harvested PFC tissue twenty four hours after the last ethanol binge and
immunostained the tissue with the MBP antibody.
The corpus callosum was used as anatomical landmark, but was excluded
from 20X images used for quantification. We visually observed slight variability of
MBP immunostaining in the PFC (Figure 4). The mean values of the uncorrected
integrated densities were used to compare relative MBP immunoreactivity (Figure
5). We performed a two-way ANOVA with sex and treatment as factors across all
four groups to assess for any statistically significant differences across the four
groups from the immediate time point. Two-way ANOVA on adolescents
harvested at PND 43 revealed no main effect of treatment on MBP protein
expression (F(1,31) = 0.582, p = 0.452) nor was there a main effect of sex (F(1,31)
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= 0.151, p = 0.701). There was no interaction effect between sex and treatment
(F(1,31) = 0.00572, p= 0.940) thus no post-hoc tests were conducted. The
significance level was set to 0.05. We concluded there were no notable alterations
in MBP protein levels at PND 43.
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MBP immunoreactivity in adult PFC tissue (PND 66)
To assess the persistent effects of binge ethanol exposure, we proceeded to
immunostain PFC tissue at PND 66, three weeks after the last ethanol binge, with
the MBP antibody. Here again, we visually observed slight variability in MBP
immunostaining among the four groups (control males, ethanol males, control
females, ethanol females) in the persistent time point (Figure 6). We quantified the
uncorrected integrated density values (without background subtracted) and
averaged the values for each group (Figure 7).
However, we found no statistically significant differences between groups.
Two-way ANOVA on adults harvested at PND 66 revealed no main effect of
treatment ( F(1,27) = 0.181, p = 0.675) nor did it reveal a main effect of sex (
F(1,27) = 0.00641, p = 0.937). There was no interaction effect present ( F(1,27) =
0.0235, p = 0.880). Alpha level to determine significance was set to 0.05. We
determined that binge ethanol exposure results in no significant alterations in MBP
immunoreactivity in the PFC at PND 66 (Figure 7).
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Fluorescence-based Western blot assays for MBP: PFC tissue (PND 43)
Fluorescence-based Western blot experiments were performed as an
additional quantitative measure of MBP relative abundance (see Appendix for
MBP immunostained membranes with adolescent PFC protein). The relative
abundance of MBP protein was normalized to beta-actin (loading control protein).
We visually observed MBP at four molecular weights (14 kDa; 17 and 18.5 kDa
quantified as a doublet band; 21.5 kDa) across the different treatment groups
(Figure 8) and quantified the total MBP immunoreactivity ranging from 14 kDa to
21.5 kDa and the separate immunoreactivity levels at the four molecular weights
(Figure 8).
We observed that ethanol males displayed a slight but not significant (n.s.)
trend towards decreased MBP protein expression as compared to control males at
all molecular weights, while the ethanol females appeared to show a slight trend
towards increased MBP protein expression or stayed relatively similar to control
females. Separate two-way ANOVA tests were completed to assess for significant
differences in total MBP relative abundance and at the various molecular weights
visualized on the fluorescent PVDF membrane (Figure 8).
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Beta-actin: molecular weight approximated to 47 kDa
We first completed a two-way ANOVA with sex and treatment as factors to
confirm there were no statistically significant differences in our loading control
mean values (beta-actin, molecular weight 47 kDa). Two-way ANOVA revealed
no statistically significant differences i.e. no main effects of sex (F(1,27) = 1.793, p
= 0.193), treatment (F(1,27) = 2.512, p = 0.126) and no interaction effect (F(1,27)
= 0.00165, p = 0.968). From these statistical findings, we determined the visually
observed variability in MBP relative abundance was not due to inconsistent sample
loading.
We then performed a two-way ANOVA with sex and treatment as factors in
order to assess for statistically significant differences between treatment groups for
MBP relative abundance. For total MBP protein relative abundance (molecular
weights ranging from 14 kDa to 21.5 kDa) two-way ANOVA revealed no main
effect of sex (F(1,27) = 0.00218, p = 0.963) nor was there a main effect of
treatment (F(1,27) = 0.748, p = 0.396). No interaction effect between sex and
treatment was present (F(1,27) = 2.150, p = 0.156). We proceeded to assess the
relative MBP abundance at the various molecular weights. The two-way ANOVA
assessing the relative abundance for MBP at 14 kDa revealed no main effect of
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sex (F(1,27) = 0.0552, p = 0.816) nor was there a main effect of treatment (F(1,27)
= 0.204, p = 0.655). There was no interaction effect (F(1,27) = 2.277, p = 0.1444).
We visually observed two bands at 17 kDa, 18.5 kDa molecular weights and
quantified these bands as a doublet. The two-way ANOVA for mean values at 17
and 18.5 kDa showed no main effect of sex (F(1,27) = 0.0413, p = 0.871) nor was
there a main effect of treatment (F(1,27) = 1.016, p = 0.323). No interaction effect
was present (F(1,27) = 2.372, p = 0.137).

When assessing relative MBP

abundance at 21.5 kDa, two-way ANOVA revealed there was no main effect of sex
nor was there a main effect of treatment (F(1,27) = 0.0134, p = 0.909), (F(1,27)
=1.943, p =0.176) and no interaction effect (F(1,27) = 2.189, p = 0.152).
Chameleon ™ Kit Prestained ladder/molecular weight marker was loaded with 2.5
ul of 700 nm channel and 2.5 ul of 800 nm channel in order to estimate the
unknown protein quantities (LICOR, Lincoln, NE, catalogue # P/N: 928-90000),
and observed MBP molecular weight values were the cited predicted values in the
literature (Akiyama et al 2002; Boggs 2006; Devine-Beach et al 1990).
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Fluorescence-based Western blot assays for MBP: PFC tissue (PND 84)
We conducted fluorescence-based Western blot experiments using PFC
sample lysates from adult PFC tissue (see Appendix for MBP immunostained
membranes with adult PFC protein). Similar to the Western blot experiments on
adolescent tissue sample lysates, we included beta-actin loading control and
normalized all quantified MBP relative amounts to actin. The blot displayed MBP
at four different molecular weights (14 kDa; 17 kDa and 18.5 kDa quantified as a
doublet band; 21.5 kDa). We quantified total MBP as well as the MBP amounts at
each of the four molecular weights (Figure 9). Ethanol males appear to show a
slight but not significant trend towards increased relative MBP abundance as
compared to the control males, while females appear to be relatively similar
between ethanol and control groups. To determine if statistical differences were
present, we performed separate two-way ANOVA statistical tests with sex and
treatment as factors on total MBP relative abundance and at each of the distinct
molecular weights. Significance level was set to 0.05 for all statistical tests
reported hereafter.
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Beta-actin: molecular weight approximated to 47 kDa
Similar to the Western blot assays completed with immediate time point
sample lysates (PND 43), we completed a two-way ANOVA with sex and
treatment as factors on the actin mean values in order to confirm that no
statistically significant differences were present. Two-way ANOVA revealed no
main effect of sex (F(1,20) = 0.0512, p = 0.824), no main effect of treatment
(F(1,20) = 0.0563, p = 0.815), and no interaction effect (F(1,20) = 0.00165, p =
0.968). Thus, we confirmed that the observed variability seen in our blots were
unlikely due to inconsistent sample loading.
The two-way ANOVA for total MBP relative abundance (molecular weight
ranging from 14 to 21.5 kDa) revealed no statistically significant differences
between groups. There was no main effect of sex (F(1,20) = 0.0521, p = 0.822) nor
was there a main effect of treatment (F(1,20) = 1.024, p = 0.326). No interaction
effect was noted (F(1,20) = 1.752, p = 0.203). Two-way ANOVA for mean values
at 14 kDa revealed no main effect of sex (F(1,20) = 0.00578, p = 0.940), no main
effect of treatment (F(1,20) = 0.948, p = 0.344), and no interaction effect (F(1,20)
= 1.338, p = 0.263). The two-way ANOVA analyzing the mean values at molecular
weights 17 kDa and 18.5 kDa (quantified as a doublet band) revealed similar
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findings. There were no main effects of sex (F(1,20) = 0.0984, p = 0.758 ),
treatment (F(1,20) = 1.256, p = 0.278), nor was there an interaction effect (F(1,20)
= 2.384, p = 0.141) at molecular weights 17 and 18.5 kDa. There were no
statistically significant findings at 21.5 kDa. The two-way ANOVA revealed no
main effect of sex (F(1,20) = 0.181 , p = 0.676), no effect of treatment (F(1,20) =
0.404 , p = 0.533), and no interaction effect (F(1,20) = 0.532 , p = 0.476) at
molecular weight 21.5 kDa.
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Fluorescence-based Western blot assays for PLP: PFC tissue (PND 43)
We performed fluorescence-based Western blot experiments on adolescent
PFC sample lysates (see Appendix for PLP immunostained membranes with
adolescent PFC protein) and assessed PLP immunoreactivity (Figure 10). PLP
relative abundance was normalized to actin loading control protein and quantified
(Figure 10). Two-way ANOVA with sex and treatment as factors were completed
to assess for any statistically significant differences between samples. Two way
ANOVA revealed no main effect of sex (F(1,27) = 0.954, p = 0.339) and no main
effect of treatment (F(1,27) = 0.219, p = 0.644) on PLP protein expression
(molecular weight 23 kDa). No interaction effect was present (F(1,27) = 0.867, p =
0.362). Significance level for all statistical tests is 0.05. The Chameleon protein
ladder was used to approximate molecular weight for PLP; the observed molecular
weight is consistent with the range for the anti-PLP antibody used in these Western
Blot assays.
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Fluorescence-based Western blot assays for PLP: PFC tissue (PND 84)
We conducted additional Western blot experiments using adult PFC sample
lysates (see Appendix for PLP immunostained membranes with adult PFC protein)
to assess potential alterations in PLP immunoreactivity (Figure 11). All relative
PLP amounts were normalized to actin. Two-way ANOVA was performed (with
sex and treatment as factors) to determine potential significant differences. There
was no effect of sex, no effect of treatment and no interaction effect on PLP
(molecular weight 23 kDa) protein expression (F(1,20) = 1.362, p = 0.259),
(F(1,20) = 2.447, p = 0.136), (F(1,20) = 0.129, p = 0.724). Significance level for all
statistical tests was set to 0.05.
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Sex Differences Between Treatment Groups
The third aim of this project was to analyze potential sex differences
following adolescent binge ethanol exposure. We formed the a priori hypothesis
that males would show a decrease in myelin-related protein expression as
compared to females, based on our earlier microarray findings (Wolstenholme et al
2017).
We performed multiple two-way ANOVAs with sex and treatment as factors
and found no main effects of sex from both our immunohistochemistry and
Western blot experiments. However, our western blot protein quantification
graphically revealed the appearance of slight but not significant trends across our
myelin proteins MBP and PLP such that adolescent ethanol males displayed a trend
towards decreased protein expression as compared to control males (Figure 8 and
Figure 10); this trend shifted such that adult ethanol males displayed a slight trend
towards increased myelin protein expression (Figure 9 and Figure 11). We also
noted that our ethanol females tended to visually display similar levels of myelin
protein expression as compared to control females in both adolescence and
adulthood. Thus, we sought to determine if the relative basal expression of myelin
proteins differed between sexes and across time. We performed two-way ANOVAs
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with time point (immediate, PND 43; persistent, PND 84) and sex (male, female)
as factors on only control animals (Figures 12).
Sex Differences from MBP Western Blot assays for control animals
There were no significant differences in sex for total (molecular weight
ranging from 14 kDa to 21.5 kDa) MBP immunoreactivity ( F(1,25) = 1.612, p =
0.218), 14 kDa relative abundance (F(1,25) = 1.469, p = 0.238), 21.5 kDa (F(1,25)
= 0.0638, p = 0.803), bands at 17 and 18.5 kDa were quantified as a doublet (F(1,
25) = 2.238, p = 0.149). However, a main effect of time point was noted (F(1,25) =
47.968, p < 0.05) where total MBP expression was greater in adults (Figure 12A).
Sex Differences from PLP Western Blot assays for control animals
In control animals, we found an interaction effect between sex and time
point with respect to PLP relative expression (F(1,25)= 5.982, p = 0.023).
Student-Newman-Keuls post hoc analyses revealed control females at the
persistent time point expressed significantly more PLP protein than their adult
control male counterparts (Figure 12 B). In addition, we noted that adult control
females expressed significantly more PLP protein than adolescent control females
(p < 0.05). Significance level for all reported results was set to 0.05.
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Puberty Onset and Progression Assessments
A notable study found that females experienced sexual maturation at a
relatively faster rate than males, and males displayed significantly decreased
myelin density following binge ethanol exposure (Richardson et al 2019). These
findings of faster sexual maturation in females were consistent with prior literature
(Vetter-O’Hagen and Spear 2012). Richardson et al noted differential rates in
sexual maturation could be a factor in how susceptible myelin density is to ethanol
insults. However, the aforementioned study did not directly assess a logical follow
up question, that is, if ethanol can affect sexual maturation in males and females.
We sought to assess if ethanol treatment delays sexual maturation and analyze
potential sex differences within the groups.
For our second cohort of mice, we performed routine visual assessments for
external signs of puberty onset in both our ethanol and control animals in order to
assess if ethanol affects sexual maturation (Figures 13-14). We then performed
two-way ANOVA with sex and treatment as factors to assess the mean PND age at
puberty onset (Figure 15). The two-way ANOVA was completed with sex and
treatment as factors in order to assess potential treatment effects. We visually
observed males displayed external signs of puberty slightly later than their female
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counterparts (Figures 13-14). The two-way ANOVA confirmed this observation
was in fact statistically significant (Figure 15). There was a main effect of sex
(F(1,39) = 10.092, p < 0.05) such that females displayed significantly lower mean
PND ages at puberty onset as compared to males (Figure 15). We also found a
main effect of treatment such that ethanol treated animals displayed significantly
higher mean PND ages as compared to control animals (Figure 15, F(1,39) =
6.875, p < 0.05), although no interaction effect was found.
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Chapter 4: DISCUSSION
Alterations in white matter and myelin-related protein expression following
ethanol consumption is an area under active investigation. The molecular
mechanisms of ethanol that result in these alterations are still being determined
(Lewohl 2000; Lewol 2005; Wolstenholme et al 2017). The main objective of this
thesis was to rigorously assess the effects of adolescent binge ethanol exposure on
myelin-related (MBP and PLP) protein expression in the PFC, and in doing so,
better understand the potential molecular consequences of excessive alcohol
consumption.
MBP immunoreactivity in adolescent PFC tissue (PND 43)
In experiment one, we used an adolescent binge ethanol exposure paradigm
where all animals were intermittently dosed with 4 g/kg ethanol or water through
PND 29-42. We harvested PFC tissue twenty four hours following the last ethanol
binge (PND 43, adolescent immediate time point) to assess changes in MBP
expression using semi-quantitative immunohistochemistry. Our experimental
design included four groups (i.e. control males, control females, ethanol males,
ethanol females) to allow for the study of potential sex differences and treatment
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effects following binge ethanol exposure. Ultimately, we found no significant
alterations in MBP immunoreactivity following binge ethanol exposure between
our control and ethanol treated groups.
MBP immunoreactivity in adult PFC tissue (PND 66)
We also aimed to assess if potential alterations in myelin protein expression
persist into adulthood. Our experimental design remained the same for this second
cohort of mice, with a 4g/kg dose of either ethanol or water from PND 29-42. The
second cohort of mice were abstinent from binge ethanol exposure for three weeks
following the dosing paradigm and were harvested at PND 66 (persistent time
point). There were no statistically significant differences between the ethanol
treated animals and the animals given vehicle.
It is well established that adolescent binge ethanol exposure is linked with
reduced white matter in the frontal cortex (Bava et al 2013; Richardson et al 2014;
Richardson et al 2019). Others have used immunohistochemistry with free-floating
sections, specifically assessing degraded myelin basic protein (dMBP) following
binge ethanol and found significant increases in dMBP at the dorsal medial border
of corpus callosum forceps minor (Richardson et al 2014). Thus, we considered
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the areas in our study that resulted in no statistically significant findings in myelin
protein expression following binge ethanol exposure.
We first considered that our method of quantification was not as rigorous.
Here, we solely used the uncorrected integrated density values without background
correction. However, reliable and accurate quantification should utilize the
corrected total cell fluorescence (CTCF) i.e. a corrected integrated density value
that removes background noise (“noise”) (El-Sharkawey, in submission;
Verdaasdonk 2014). Thus, it is possible the manner in which we quantified our
data was not representative of the potential changes in MBP immunoreactivity.
These potentially unrepresentative mean values may not truly convey the
consequences of binge ethanol on white matter integrity. Therefore, if significant
alterations were present, our method of data acquisition did not readily reveal
them.
Another technical consideration is the thickness in our sections (25 microns),
other published findings have used 35 um thick sections (Richardson et al 2014;
Richardson et al 2019) in their immunostaining experiments, thus it is possible that
the thinner sections were more susceptible to damage during tissue processing,
making consistent data acquisition more challenging. The concern for slightly
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inconsistent data acquisition prompted a standardized imaging acquistion process
that avoided damaged areas, however, this method was subject to some
experimenter bias which could have impacted the final results (experimenter was
blinded to sex, treatment and time point at the time of imaging acquistion and
quantification).
Biological considerations are also warranted. This study formed an a priori
hypothesis based on our prior mRNA findings where adolescent binge ethanol
decreased myelin-related gene expression. We relied on our previous findings in
order to hypothesize that binge ethanol will decrease myelin protein expression.
However, we erred in heavily relying on the central dogma of molecular biology as
a mechanism rather than a potential flow of biological information. There are
potential epigenetic regulatory mechanisms at play as well. These mechanisms
could have potentially altered the transcription levels, and resulted in downstream
effects in protein expression, which may have impacted our results. For example,
H3K9me, an epigenetically modified version of histone 3 protein, is notable for its
presence on oligodendrocyte progenitor cells (OPCs) and mature oligodendrocytes
(Liu et al 2015). Our laboratory has found evidence of slight alterations to the
H3K9 mark following binge ethanol exposure (Wolstenholme et al 2017). While
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H3K9 methylation was not significantly reduced by ethanol, future studies may
consider assessing the methylation of this mark in conjunction with myelin protein
expression.
Fluorescence-based Western blot assays for MBP: PFC tissue (PND 43)
In experiment two, fluorescence-based Western blotting was completed to
employ a semi-quantitative technique in conjunction with the immunostaining
from experiment one. Animals (four groups ie. control males, control females,
ethanol males, ethanol females) followed the same adolescent binge ethanol dosing
paradigm, and sample lysates (PND 43) were prepared and multiplexed on a
fluorescent-PVDF membrane with beta-actin; there were no statistically significant
differences in beta-actin mean values (p> 0.05). We found no statistically
significant differences in adolescent MBP expression between group means. We
noted, as evidenced by the error bars, there was reasonably large variability within
the treatment groups. Thus, we could not rule out the potential for tissue dissection
variability. Variable tissue dissections would have altered the white matter present
and possibly increased our sample-to-sample variation.
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Fluorescence-based Western blot assays for MBP: PFC tissue (PND 84)
Similarly, sample lysates (PND 84) were prepared and multiplexed on a
fluorescent-PVDF membrane with beta actin; no statistically significant differences
were present in beta actin mean values (p>0.05). Protein expression was analyzed
by quantifying total MBP peak intensities and the four distinct bands visualized on
the blot to assess any difference in trends across the observed molecular weights
(14 kDa; 17 and 18.5 kDa quantified as a doublet; 21.5 kDa). We note that these
observed molecular weights were approximated with the Chameleon protein ladder
and we consulted with the literature to confirm that these observed molecular
weights matched the predicted molecular weights for the various isoforms.
Prior studies have observed two bands at the major classic isoforms 18.5
kDa and 14 kDa (Karthigasan et al 1996, Lewohl 2005). These isoforms of MBP
are abundant in compact myelin. Thus, they have a suggested role in the formation
and stabilization of myelin (Akiyama et al 2002; Karthigasan et al 1996). However,
the minor isoforms (17 kDa, 21.5 kDa) may have a role in remyelination (Capello
et al 1997). While further work is required to fully understand the functions of
these various isoforms, we speculate that our slight but not significant trends
toward decreased myelin protein expression (n.s.) seen in adolescent ethanol males
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as compared to the slight (n.s.) trend towards increased myelin protein expression
seen in adult ethanol males suggests possible recovery of myelin protein following
abstinence. This potential recovery may involve the minor MBP isoforms, but
further work is required to assess this possibility. In general, we observed similar
slight (n.s.) trends across the different isoforms for MBP, specifically in the
ethanol males following adolescent binge ethanol (Figure 8) that appeared to shift
during adulthood (Figure 9). The ethanol females appeared to display relatively
similar levels of myelin protein expression as compared to control females in
adulthood (Figure 8, Figure 9), suggesting potential differences in PFC
development.
PLP immunoreactivity in C57BL/6J (untreated tissue)
We were unable to study PLP protein levels through immunostaining due to
concerns for nonspecific binding of endogenous murine immunoglobulins (see
Appendix for Supplemental Figures 1-2). However, others have been able to
successfully conduct immunohistochemistry studies with this proteolipid protein
antibody (Buccinna, et al 2009). Thus, future experiments could employ the use of
another PLP antibody that has been validated for reproducible, specific and
selective binding of the target of interest. Additionally, others have improved
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non-specific binding in PLP antibodies in murine studies through the use of an
avidin-biotin complex

(ABC) method and confirmed specificity with isotype

controls (Goodpaster et al 2014). While our exact antibody was not used in the
aforementioned study, their experimentation on numerous mouse based primary
antibodies was rigorous and they replicated specific anti-mouse binding with
minimal background. Thus, it is possible that repeat experiments using the ABC
method along with isotype negative controls could allow for a better evaluation of
PLP immunoreactivity.
Fluorescence-based Western Blot assays for PLP : PFC tissue (PND 43)
Our experimental design remained the same (four groups i.e. control males,
ethanol males, control females, ethanol females), dosed with 4g/kg of ethanol or
water from PND 29-42, with tissue harvested at PND 43. Sample lysates were
prepared, and the stripped fluorescent-PVDF membrane was blocked and
subsequently probed with PLP antibody. All PLP mean values were normalized to
beta-actin; beta-actin statistical analyses revealed no significant differences
between means (p > 0.05). We found no statistically significant differences in PLP
relative abundance between groups. However, we observed that the mean relative
abundance of PLP displayed the same slight (n.s.) trend seen in MBP. Specifically,
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we noted that adolescent ethanol males appeared to show a small but not
significant trend towards decreased PLP protein expression as compared to their
control male counterparts (Figure 10). Ethanol females appeared to show a slight
trend towards increased PLP protein expression (Figure 11). Here again, we
believe these slight (n.s.) trends could be suggestive of possible differences in PFC
development.
Fluorescence-based Western Blot assays for PLP : PFC tissue (PND 84)
Similar to the Western Blot assays for PLP at PND 43, the sample lysates
(PND 84) from the adolescent binge ethanol exposure study were prepared, and the
stripped fluorescent-PVDF membrane was then blocked and probed with PLP
antibody. All PLP mean values were normalized to beta-actin; no statistically
significant were different in mean actin values i.e. p > 0.05. While we found no
significant differences in relative PLP abundance between our four groups. We
noted that the adult ethanol animals displayed a trend towards increased PLP
protein expression as compared to control animals.
Both experiments revealed a lack of persistent myelin protein alterations
following adolescent binge ethanol exposure. This finding seen across our
immunohistochemistry and Western blot assays may be evidence of white matter
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recovery (Pfefferbaum et al 1995; Shear et al 1994; Lewohl et al 2005). However
studies have found conflicting evidence on how ethanol exposure affects myelin
related protein expression, specifically MBP and PLP, in the frontal cortex
(Lewohl et al 2005; Samantaray et al 2015). In a human study, controls and
uncomplicated alcoholics had no significant differences in myelin-related protein
expression in the superior frontal gyrus and the primary cortex (Lewohl et al 2005).
This result is notable because Lewohl et al previously found MBP showed
decreased expression at the mRNA level in the superior frontal gyrus (Lewohl
2000). Thus, ethanol’s molecular mechanisms may not be fully understood by
step-wise analysis of mRNA encoded myelin-proteins.
Eukaryotic transcription and translation processes are physically separated
by the nuclear membrane (Berg et al 2002), specifically transcription occurs inside
the cell’s nucleus, while translation occurs in the cytoplasm. This spatial separation
introduces a temporal component, as transcription and translation will not occur in
tandem as is the case for prokaryotes (Berg 2002). Thus, eukaryotes are able to
regulate gene expression in a more intricate fashion, as the regulatory mechanisms
between transcription and translation are distinct. We speculate that the different
regulatory mechanisms in transcription and translation may be a possible
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explanation for why our prior findings of significant decreases in myelin-related
mRNA expression were not explicitly found at the myelin-protein level.
At the level of transcription, there is the possibility for epigenetic regulatory
mechanisms that could affect mRNA expression. The potential alterations in
mRNA expression may be short lived i.e. faster mRNA turnover rates whereas
MBP and PLP have notably slower turnover rates (Sabri et al 1974). Thus, these
differences in life spans may explain why we did not see the prior significant
decreases in mRNA expression following binge ethanol manifest into significant
decreases at the myelin-protein level. The potential for post-translational
modifications should also be considered. MBP and PLP are notable for their longer
life spans and both proteins undergo extensive post-translational modifications e.g.
phosphorylation and prenylation to confer increased stability (Messier and
Bizzozero 2000; Zhang et al 2012). Thus, it is logical that the increased stability of
these myelin proteins made them less vulnerable to significant decreases in
expression following adolescent binge ethanol. The slight (n.s.) trends towards
decreased protein expression in adolescent ethanol males coupled with the small
trend towards increased protein expression in adult ethanol animals, suggests that
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ethanol may affect myelin protein expression, however future studies are needed to
temporally assess when these potential alterations are occurring.
Sex Differences
We noted no main effects of sex in the statistical analyses of our ethanol and
control animals from our Western Blot assays and immunohistochemistry
experiments. However, we observed that adolescent ethanol males displayed a
small but not significant trend towards decreased myelin protein expression,
specifically in MBP and PLP, as compared to control males (Figure 8, Figure 10);
ethanol females were relatively similar to control females during adolescence
(Figure 8, Figure 10). In adulthood, ethanol males appeared to show a slight trend
towards increased MBP and PLP expression; adult females displayed relatively
similar levels of MBP and PLP expression in ethanol and control groups (Figure 9,
Figure 11).
We speculate that these slight trends may be suggestive of possible
neurodevelopmental differences between the sexes. Prior studies have noted that
adolescent males displayed decreased myelin density in the mPFC following binge
ethanol (Richardson et al 2014) while adolescent females did not display notable
myelin decreases following binge ethanol, suggesting sex differences (Richardson
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et al 2019).

These prior findings coupled with our noted trends within the

adolescent and adult time points led to the assessment of basal myelin protein
expression in control animals to further assess possible sex differences.
Specifically, we performed a two-way ANOVA with sex and time point (PND 43,
adolescent versus PND 84, adult) as factors to assess potential sex differences in
basal MBP and PLP expression. Ultimately, we found that total basal MBP protein
expression was significantly lower in adolescence (main effect of time point, p <
0.05, Figure 12A), reiterating that adolescence is a critical neurodevelopmental
period. We also found an interaction effect between sex and time point in basal
PLP expression where adult females had significantly greater levels of PLP
expression as compared to adult males and adolescent females (Figure 12B). This
increased protein expression in adult females further suggests possible
neurodevelopmental differences between the sexes.
The adolescent transitional period encompasses the sexual maturation period
i.e. puberty (Vetter-O’Hagen and Spear 2012). Prior studies have found that
females may experience sexual maturation relatively faster than males (Richardson
et al 2019) and earlier studies have found that introducing ethanol may delay
sexual maturation in females (Dees and Skelley 1990; Emanuele et al 2002). Thus,
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we sought to assess if ethanol affects sexual maturation in both sexes. We assessed
all ethanol and control animals for external signs of puberty onset and observed
that females tended to display signs slightly earlier than males (Figure 13 versus
Figure 14). We also observed that ethanol animals appeared to show external signs
of puberty onset relatively slower than control animals in both sexes (Figure
13-14).
To specifically assess for statistical differences in mean PND age at puberty
onset, we performed a two-way ANOVA with sex and treatment as factors. We
found that ethanol animals displayed external signs of sexual maturation at
relatively later PND ages (Figure 15). We also found that females displayed
external signs of puberty onset at an earlier age than males (Figure 15). These
findings coupled with our findings from relative basal MBP and PLP expression
may imply that males are more susceptible to ethanol insults as compared to
females. However, further work is required to temporally assess this directly.
Our lab

previously found that binge ethanol exposure leads to reduced

myelin-related gene expression, in genes including Mbp and Plp immediately after
the adolescent period (PND 43)

(Wolstenholme et al 2017). Specifically,

microarray data found that binge ethanol exposure significantly decreased Mbp and
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Plp gene expression in adolescent ethanol males compared to control males. Thus,
we may have replicated this finding at the myelin-related protein level as we have
noted slight but not significant trends for males to have decreased MBP and PLP
protein expression immediately following binge ethanol exposure. In addition, our
western blot data at the persistent time point (PND 84), displays a small trend
toward increased relative myelin protein abundance (n.s.) in ethanol males as
compared to control males. These slight trends in myelin protein expression
following binge ethanol

may indicate possible recovery of myelin protein

expression following abstinence which is consistent with prior studies
(Pfefferbaum 1995; Shear 1994) as well as our microarray results at the mRNA
level (Wolstenholme et al 2017). When we consider our significant findings in
basal myelin protein expression as well as puberty onset, we note that potential
myelin protein recovery may vary between the sexes and possess a temporal
component. We speculate that these findings may provide the framework for
follow up studies to temporally assess when myelin related protein expression
recovers after binge ethanol exposure and how these potential structural alterations
in myelin protein differ between the sexes.
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Study Limitations
In experiment one, quantification of MBP protein was completed using the
uncorrected integrated densities and images were not background corrected. The
rationale for this method quantification was due to the fact that the image
acquisition included vast fluctuations in background, thus the calculated CTCF was
not used. These fluctuations in background were, in part, due to variable staining
across sections but also damaged sections following tissue processing. The
experimenter avoided regions of excessive damage, highly fluorescent areas that
were not characteristic of our target protein, and areas with excess mounting media
to ensure that data would not be skewed in any particular direction. However, in
excluding these areas, consistent quantification of the immunostained sections was
not completed as rigorously. Thus, only 3 representative sections per animal were
used. In general, quantification of immunostained images (despite experimenter
being blinded to sex, treatment and time point) were subject to a small degree of
bias that could have affected the data and subsequent results.
Regarding the PLP immunoreactivity studies, the PLP anti-mouse antibody
displayed non-specific binding despite the use of a M.O.M immunodetection kit,
which led us to only assess MBP immunoreactivity through semi-quantitative
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immunohistochemistry. Experiment 1 would have benefited from testing other
sources for a PLP antibody or from analyzing other myelin related protein markers
such as myelin associated glycoprotein (MAG), or myelin associated
oligodendrocyte basic protein (MOBP). Both of the aforementioned myelin
proteins were notable in that the ethanol males showed a robust decrease in mRNA
levels for the genes Mobp and Mag (Wolstenholme et al 2017). Thus, more
conclusions of ethanol exposure on myelin-related protein could be formulated
because of the assessment of other proteins that play different functional roles in
myelin formation and maintenance.
In experiment two, MBP and PLP protein expression were studied using
tissue samples from prior studies collected several years ago. While these samples
were maintained at proper temperature conditions, it is possible that fresher tissue
may have yielded less variable results. In addition, when studying MBP levels, the
same PVDF membranes were first probed with MBP, stripped, and reprobed with
PLP. We compared our observed molecular weights to the predicted values for
each protein and normalized these values to a loading control. We visually
observed that PLP displayed a lower signal compared to MBP at both time points
(PND 43, Figures 8 vs Figure 10; PND 84, Figures 9 vs Figure 11, see Appendix
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for supplemental Western data). Fluorescent PVDF membranes are considered
more robust than nitrocellulose membranes and are recommended for protocols
involving antibody stripping (Bass et al 2016). However, it is possible that the
decreased PLP signal may be attributed to the stripping reagents. This possibility
would affect our western blotting results.
These western blot experiments also did not include a negative control,
presence of a negative control (i.e. a sample lysate from a cell line devoid of
myelin) may have allowed for improved comparison of the samples and confirm
that our commercial antibodies were not displaying non-specific binding that
would skew our results. Our collaborators in the Dr. Miles’ laboratory routinely
use these antibodies under the same conditions and have validated their specificity.
Additionally, they have found MBP and PLP perform at similar molecular weights
as we have reported. An additional study limitation for our Western Blot assays
was the potential for tissue dissection variability. While we attempted to optimize
our sample selection through the BCA assay, we must consider the potential for
human error. Thus, some PFC samples may have possessed more white matter than
others, this could also account for the sample-to-sample variation observed in our
fluorescent-blots.
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Our analysis of sex differences included the tracking of pubertal
onset/progression in the second cohort of animals to assess if ethanol treatment
affects sexual maturation. However, an improved experimental design would
include these assessments in all animals being tested. In addition, future studies
should consider other measures for comparisons between sexes. For example, we
subjectively determined “partial puberty progression in males” (corresponding to
the numeric score of 2) and used this metric to track the number of males in a
pubertal state. However, this method was subject to a high level of bias, coupled
with experimenter inexperience (although the experimenter’s confidence in
assessments improved over time). Thus, future male puberty assessments should
consider assessing for external signs of the balano-prepuptial separation, others
have reported published findings using this assessment to correlate with
histological slides in preclinical studies with rats (Gaytan et al 1988, Korebrot et al
1977)
Future Directions
Immunohistochemistry in combination with fluorescence-based Western
blots with fresher PFC tissue should be repeated to assess if these thesis findings
are replicable at the protein level. PLP anti-mouse antibody experiments using a
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commercial M.O.M kit should be repeated to assess if non-specific binding is still
present, however future studies should include an isotype control to further validate
the antibody’s specificity. Experimenters should also consider including an antigen
retrieval step with future PLP immunoreactivity studies, while our antigen is robust
against tissue fixation, this additional step may yield more improved and consistent
staining results. A comparative experiment using the PLP anti-mouse antibody
with the ABC system in the M.O.M kit and a biotin-free system should also be
performed to see if there is a difference in the level background observed
(Goodpaster et al 2014). Western blot experiments should include negative
controls and a comparative analysis should be done looking at MBP and PLP
protein levels following a stripping protocol versus MBP and PLP being probed on
separate blots. These experiments will provide further information on the technical
effects of stripping reagents. Western blot experiments should consider including
another myelin-related protein target e.g. myelin associated protein MAG to assess
if

protein levels after binge ethanol follow similar patterns of alteration in

myelin-related gene expression.
Future studies should also consider analyzing protein levels at various time
points within adulthood to assess when this potential recovery is occurring e.g.
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PND 42, PND 50, PND 66, PND 84. These experiments will assess the protein
level changes. In addition, future studies should consider analyzing the OPC and
mature oligodendrocyte myelin ultrastructures through electron microscopy, as
assessing these myelin producing cells for potential alterations after binge ethanol
will provide further information, upstream of myelin protein expression. Future
work should incorporate behavioral assays such as the novel object recognition
task (Wolstenholme et al 2017) to assess potential PFC-mediated, behavioral
effects of altered myelin-related protein expression, as they will be correlated with
the molecular results. Additional behavioral assays should assess social recognition
as preclinical studies have implicated PFC in social cognition (Avale et al 2011;
Finlay et al 2015). The behavioral assays coupled with the molecular studies may
uncover a mechanism by which ethanol acts to alter myelin related protein. These
future studies may allow for the uncovering of a mechanism of myelin recovery
following binge ethanol exposure and will have excellent translational merit.
Conclusion
In these studies, we found a slight (n.s.)

trend towards decreased

myelin-related (MBP, PLP) protein expression in adolescent ethanol males that
appeared to recover in adulthood. These findings are notable because we
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previously showed adolescent binge ethanol exposure leads significantly decreased
myelin-related gene expression (including Mbp, Plp) (Wolstenholme et al 2017).
While we did not find significant alterations in myelin-related protein expression
following binge ethanol, we found that basal MBP expression is significantly lower
during adolescence and that basal levels of PLP expression are significantly greater
in adult females as compared to adolescent females and adult males. Additionally,
we found that ethanol delays sexual maturation and males generally display signs
of puberty onset later than females. Taken together, we may have found potential
structural alterations in myelin protein expression following binge ethanol
exposure that may not necessarily manifest into decreased myelin protein
expression along with possible evidence of differences in PFC development
between the sexes. This assessment of myelin-related protein expression will lay
the foundation for follow up studies that will further investigate how ethanol
mechanistically affects myelin in the CNS.
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Appendix
Supplemental Methods
Tissue harvest
PBS recipe- 1.82 L of 1X phosphate buffered saline (PBS) solution from
10X stock, 1.8 L MilliQ water, 200 mL 10X PBS stock solution, VitaScientific,
Beltsville, MD, catalogue # QBIC20044;10X PBS recipe includes 1.78 g of 100
mM Na2PO4·2H2O, 0.24 g of 27 mM KH2PO4, 8 g of 1.37 M NaCl, 0.2 g of 27
mM; 400 mL MilliQ water, total volume of 3 L)
Cryosectioning
Cryostat machine (Leica CM 1950, Leica Biosystems, Buffalo Grove, IL)
was used for all cryosectioning. Cryostat object temperature and chamber
temperature were set to -16oC and -19oC respectively. Frozen tissue was placed in
the cryostat machine for approximately twenty minutes to calibrate to set
temperatures. Tissue was then oriented to the dorsolateral view and cerebellum was
removed using a cryostat blade (Leica Biosystems, Buffalo Grove, IL, catalogue #
14035838382). Optimal cutting temperature (OCT) compound (Fisher Scientific,
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Waltham, MA, catalogue # 4583) was then applied to tissue on cryostat chuck and
placed in the cryostat machine to readjust to temperatures. Coronal sections with
25 micron thickness were collected and placed serially into 12 well plates
containing a PBS and sodium azide solution (1X PBS; 0.02% w/v sodium azide,
Sigma Aldrich, St Louis, MO, catalogue # S2002-25G). Tissue was sectioned from
the area just past the olfactory bulb to approximately -2.30 mm from bregma. The
12-well plate was then labeled with animal identification number, study name,
section thickness and date. All 12 well plates were wrapped with parafilm and
stored at 4oC.
Myelin Basic Protein (MBP) immunostaining
Sections were washed in 1X PBS twice, for five minutes each wash.
Sections were then blocked in 1X-PBS-T (5% normal goat serum, Jackson
ImmunoResearch, West Grove, PA, catalogue # 005-000-121; 0.5% Triton X 100;
1X PBS solution) for thirty minutes at room temperature with gentle agitation.
Sections incubated in MBP anti-rat primary antibody solution with 400 ul per well
(1:1000, Abcam, Cambridge, UK, catalogue # 7349; 3.2 mL 1X PBS-T; 3%
normal goat serum) overnight at 4 oC

with gentle agitation. Sections were

subsequently washed three times in 1X PBS for ten minutes each with gentle

97

agitation. Sections were then incubated in the Invitrogen Alexa Fluor 594 goat
anti-rat secondary antibody solution (1:1000, Thermo Fisher, Waltham, MA,
catalogue # A11007; 0.5% Triton X 100; 3.2 mL 1X PBS) for two hours with
gentle agitation and protected from light. Sections were then washed in 1X PBS
three times for ten minutes each wash and stored in 1X PBS at 4 o C until mounting.
Each animals’ sections were placed in a separate indent free container containing
PBS and transferred to a Fisherbrand Superfrost microscope slide (Fisher
Scientific, Waltham, MA, catalogue # 12-55-0-143).
Sections were organized into columns with the most rostral section first and
the most caudal section last. Excess 1X PBS was pipetted from the microscope
slide and slides were left to dry for a short period. Vectashield Vibrance Antifade
mounting medium with DAPI (VECTOR Laboratories, Burlingame, CA, catalogue
# H-1800) was used to mount sections further, with 50 ul added to each slide.
Slides were coverslipped with Corning Cover Glass rectangle coverslips (Corning,
Corning, NY, catalogue # 2980-245) and sealed with clear nail polish. Sections for
one ethanol male animal were destroyed during the tissue mounting portion of the
experiment, leading to an N = 63 for the immunohistochemistry study.
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Myelin Proteolipid (PLP) immunostaining
We previously determined at 1:250 was the optimal concentration with a
strong fluorescent signal (without excess saturation) and minimal background.
However, we conducted follow up negative control experiments using secondary
antibody only (1:1000) on C57BL/6J (untreated) coronal sections and observed
high amounts of non-specific binding (Supplemental Figure 1)
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PLP antibody with Mouse on Mouse (M.O.M) Immunodetection reagents
Due to the fact that using a goat anti-mouse secondary antibody may lead to
the binding of endogenous mouse immunoglobulins, we purchased a M.O.M kit
and conducted a PLP (+/-) M.O.M kit experiment with proper negative controls
(sections stained with only secondary antibody without M.O.M. kit reagents,
sections stained with only secondary antibody and M.O.M. kit reagents).
Ultimately, both negative control slides revealed similar levels of non-specific
binding (Supplemental Figure 2). The concern for inaccurate localization of PLP
immunoreactivity and quantification led us to only assess MBP immunoreactivity
through immunohistochemistry.
Plate 1- M.O.M reagents with PLP antibody solutions
Three sections (C57BL/6J untreated practice tissue) per well were placed
into four wells of a 12-well plate (two plates were used, M.O.M reagents were used
on sections in plate 1 and no M.O.M reagents were used on sections in plate 2). All
sections were washed in 0.01 M PBS twice, for five minutes each wash. Sections
were then blocked in a blocking buffer (PBS with 0.5% Triton X 100; 3% normal
goat serum) for thirty minutes with gentle agitation at room temperature. Sections
in plate 1 were then incubated in the M.O.M IgG Blocking Reagent (90 ul M.O.M
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IgG Blocking Reagent, 2.5 mL PBS) for 1 hour at room temperature. Sections in
plate 1 were washed in PBS twice, for two minutes each wash. Following this step,
sections incubated in the M.O.M Diluent (600 ul M.O.M protein concentrate stock
into 7.5 mL PBS) for five minutes.
Primary antibody solutions (1:250 PLP anti-mouse, 600 ul M.O.M protein
concentrate stock, 7.5 mL PBS-T; 1:500 PLP anti- mouse, 600 ul M.O.M protein
concentrate stock, 7.5 mL PBS-T) were made, with 400 ul of each solution placed
into separate wells (2 wells total). The negative control wells were each filled with
400 ul PBS-T. The 12 well plate was stored at 4 oC for overnight incubation with
gentle agitation. All sections from plate 1 were incubated in the prepared M.O.M
Biotinylated Anti-Mouse IgG Reagent (10 ul M.O.M. biotinylated Anti-Mouse IgG
reagent in 2.5 mL PBS) for ten minutes. Sections from plate 1 were washed in
PBS-T twice for five minutes each wash.
Sections from plate 1 all four wells were then incubated in 400 ul of
secondary antibody solution (1:1000 secondary antibody; 600 ul M.O.M protein
concentrate stock, 7.5 mL PBS-T) with gentle agitation at room temperature (light
protected) for two hours. Sections were washed in PBS twice for five minutes each
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wash. Sections were then

mounted onto slides and coverslipped in the same

manner as the MBP immunostained sections.
Plate 2- PLP antibody solutions without M.O.M reagents
Three sections (C57BL/6J untreated practice tissue) per well were placed
into four wells of a 12-well plate (two plates were used, M.O.M reagents were used
on sections in plate 1 and no M.O.M reagents were used on sections in plate 2). All
sections were washed in PBS twice, for five minutes each wash. Sections were
then blocked in a blocking buffer (PBS-T, 3% normal goat serum) for thirty
minutes with gentle agitation at room temperature.
Sections in plate 2 had 400 ul of primary antibody solution placed into each
of the two wells (PLP 1:250, PLP 1:500, PBS-T, 3% normal goat serum) and the
negative control sections had 400 ul of PBS-T placed into the remaining two wells,
plate 2 was stored at 4oC for overnight incubation with gentle agitation. Sections
from plate 2 were washed in PBS-T three times, ten minutes per wash. Sections
from plate 2 were incubated in a secondary antibody solution (1:1000 secondary
antibody, PBS-T, 3% normal goat serum) for two hours (protected from light) on a
gentle rocker. Sections from plate 2 were washed in PBS three times for ten
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minutes each wash. Sections were then mounted onto slides and coverslipped in
the same manner as the MBP immunostained sections.
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Image acquisition and quantification for MBP immunoreactivity
Images were acquired using the Olympus DP74 microscope (Olympus Life
Science, Tokyo, Japan) with cellSense Standard software (Olympus Life Science,
Tokyo, Japan). Each section had a representative image taken of both hemispheres
in the Cy3 light at the 10X objective (scale bar burned in).

Images for

quantification were taken at the 20X objective with a constant exposure of 24.9
milliseconds and the Super Fluorescence (SFL) setting for all images. DAPI
counterstain of the CNS nuclei (light 1 on Olympus DP74) was observed to ensure
proper localization of myelinated axonal processes that were characteristic of MBP
staining (Ortiz et al 2019; Pajoohesh-Ganji and Miller 2019) Consistent image
acquisition was completed with two images taken for each hemisphere of a section
and at least 12 images were taken per mouse. Sections ranged from 1.40 mm
distance from bregma to 0.50 mm from bregma; no section imaged included the
corpus callosum.
Exclusion criterion for quantification included sections with severe damage
to the PFC region. Only 10X images were taken of these damaged sections for
data records. Following image acquisition, 3 representative sections were chosen
for each of the 63 animals and Allen Mouse Brain atlas (brain-map.org) was

104

referenced to ensure that region of interest was present in the field of view. All
images were quantified using ImageJ software with raw integrated density and
mean grey value measurements taken for each image.
The uncorrected integrated densities for each section (two 20X images per
hemisphere, four 20X images per section) were summed followed by the addition
of each section to determine the total integrated density for each animal.
Experimenter was blinded to sex, treatment, and time point of the animals during
the image acquisition and image quantification process. Following the
quantification, three mice from the persistent time point including one control male
and two ethanol males were removed because of excess damage to the region of
interest leading to N = 60 for the immunohistochemistry study.
Western Blots
The BCA protein assay was performed using Pierce BCA Assay kit (Thermo
Fisher, Waltham, Massachusetts, catalogue # 23227) in order to calculate protein
concentration (Walker 1994). The expected color change to light green occurred
once the working reagent was added to all wells. The plate reader measured
absorbance at 450 nm and 630 nm respectively. The replicate values from the 450
nm wavelengths were averaged and the mean standard values versus their
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respective concentrations were plotted to generate a standard curve on Microsoft
excel; the standard curve equation was used to determine the concentration of
protein based on serial dilutions of a standard BSA reagent and 10 ug of total
protein was calculated for sample and to be loaded into the gel (with loading dye
and reducing reagent).
After sample preparation, Thermo Fisher mini gel tank chambers (Thermo
Fisher, Waltham, MA, catalogue #A25977) were each filled with 200 mL of 1X
MES SDS Running Buffer (50 mL 20X MES Bolt ™ MES SDS Running Buffer,
Thermo Fisher, Waltham, MA, catalogue # B000202; 950 mL MilliQ water).
Following this step, 500 ul of NuPage Antioxidant (Thermo Fisher, Waltham, MA,
catalogue # NP0005) was added to each chamber to prevent reoxidation of protein
samples during the gel electrophoresis and transfer steps. NuPage 4-12% Bis-Tris
Protein gels (Thermo Fisher, Waltham, MA, catalogue # NP0329BOX) were
loaded with protein samples. Following the sample loading, the Chameleon ™ Kit
Prestained ladder/molecular weight marker was loaded with 2.5 ul of 700 nm
channel and 2.5 ul of 800 nm channel in order to estimate the unknown protein
quantities (LICOR, Lincoln, NE, catalogue # P/N: 928-90000). Gel electrophoresis
was run at 150 V for approximately 45 minutes using the Thermo Fisher mini gel
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tank apparatus and Bio-Rad PowerPac Basic power supply (Bio-Rad Laboratories,
Hercules, CA, catalogue # 1645050).
1X tris-buffered saline (TBS) recipe- (100 mL 10X TBS buffer solution in
900 mL MilliQ-water; 10X TBS recipe includes 2.4 g of 200 mM Tris Base, 8.8 g
of 1500 mM NaCl).
LICOR immunodetection imaging and ImageJ quantification
Membranes were imaged using the LICOR detection system and Odyssey
software with the LICOR scan preset to “membrane” and intensities set to 4 and 8
for the 700 nm and 800 nm channels respectively. All LICOR imaging scans were
saved with the Analysis folder containing 700 and 800 TIFF files. TIFF files from
the Analysis folder were downloaded into ImageJ (NIH, Bethesda Maryland) and
analysis of signal intensity was used by measuring the area of the peak intensities;
the band intensity corresponded to peak height and area of each of the peaks were
recorded. Additionally, the area of the loading control peak intensities were
recorded and all target signal peak areas were normalized to the loading control
protein (beta-actin).
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Stripping procedure for fluorescent-PVDF membranes
Following the imaging, membranes were stripped of antibodies using 1X
dilution of 5X NewBlot IR Stripping buffer for NIR Western Blots (LICOR;
Lincoln, NE; catalogue # P/N: 928-40028), membranes incubated in stripping
solution for twenty minutes at room temperature with gentle agitation. Following
the stripping period, membranes were washed in 1X TBS three times. Membranes
were then subsequently probed with the appropriate LICOR secondary antibodies
and light protected during a one hour incubation at room temperature with gentle
agitation. Membranes were then rinsed in 1X TBS-T four times for five minutes
each (with gentle agitation) followed by a brief rinse in 1X TBS. Using the LICOR
infrared detection system and Odyssey software, membranes were scanned to
detect any presence of primary antibody.
Once membranes were sufficiently stripped of previous target protein,
membranes were blocked with Intercept Blocking buffer for 15 minutes followed
by overnight incubation with PLP anti-mouse primary antibody (1:5,000; 0.2%
Tween-20; 0.02% w/v sodium azide). Membranes were then rinsed with 1X TBS-T
followed by four washes in 1X TBS-T (five minutes each wash) at room
temperature with gentle agitation. Membranes were then probed with IRDye 800
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CW Goat anti-Mouse Secondary Antibody (1:30,000; LICOR, Lincoln, NE,
catalogue # P/N: 926-32210; 0.2% Tween-20; 0.02% SDS) and incubated in the
secondary solution for one hour (light-protected). Membranes were then washed
with 1X-TBS-T and stored in 1X TBS prior to imaging with LICOR detection
system and Odyssey software. Imaging and subsequent quantification were
completed in the same manner as the MBP anti-rat blots. PLP anti-mouse blots
were normalized to actin area values from initial ImageJ quantification of MBP
and actin peak intensities.
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Supplemental Western Blot Data for MBP and PLP protein expression
Here, we present the fluorescent-PVDF membranes with MBP and PLP
expression for the adolescent (PND 43) and adult (PND 84) time points. We note
that two membranes with adolescent sample lysates (PND 43) were first probed
with MBP as well beta-actin antibodies followed by a stripping procedure and
reprobed with PLP antibody. Similarly, to assess MBP and PLP relative abundance
at the persistent time point, two membranes with adult sample lysates (PND 84)
were first probed with MBP and beta-actin antibodies, stripped and reprobed with
PLP.
We first present the ordering of the PFC sample lysates, including the
molecular weight marker (MWM); we bold the MWM term when appropriate to
indicate a greater volume of the Chameleon protein ladder present. Following the
ordering of the samples, we present the images for MBP and PLP relative
abundance. We start with MBP immunoreactivity at the adolescent time point
(PND 43, Supplemental Figure 3) followed by the adult time point (PND 84,
Supplemental Figure 4), we end with PLP immunoreactivity at both time
points(PND 43, Supplemental Figure 5 and PND 84, Supplemental Figure 6).
We note that the ordering of the samples are presented such that the samples on the
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left column correspond to the left membrane, likewise for the right column and
right membrane.
Supplemental Figure 3: MBP relative abundance following adolescent binge
ethanol (PND 43)
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Supplemental Figure 4: MBP relative abundance following adolescent binge
ethanol (PND 84)
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Supplemental Figure 5: PLP relative abundance following adolescent binge
ethanol (PND 43)

Left gel

Right gel

lane

sample

lane

sample

1

MWM

1

MWM

2

73 EF

2

35 CM

3

11 CM

3

7 CM

4

12 CM

4

15 EM

5

75 EF

5

22 EM

6

79 CF

6

62 CF

7

32 CM

7

42 CF

8

59 CF

8

46 EF

9

4 EM

9

74 EF

10

64 CF

10

55 CF

11

23 EM

11

37 EM

12

63 CF

12

8 CM

13

66 EF

13

68 EF

14

26 EM

14

27 EM

15

10 CM

15

56 CF

16

16 EM

16

MWM

115

116

Supplemental Figure 6: PLP relative abundance following adolescent binge
ethanol (PND 84)
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